Aberrant DNA methylation status of DNA repair genes in breast cancer treated with neoadjuvant chemotherapy

Genes to Cells

Volumn 18, Issue 12, 2013, Pages 1120-1130

  Watanabe, Yoshiyuki ^a   Maeda, Ichiro ^a   Oikawa, Ritsuko ^a   Wu, Wenwen ^a   Tsuchiya, Kyoko ^a   Miyoshi, Yasuo ^b   Itoh, Fumio ^a   Tsugawa, Ko ichiro ^a   Ohta, Tomohiko ^a,c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c ST MARIANNA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL;

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1 GENE; ADULT; AGED; ARTICLE; ATM GENE; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1 GENE; BREAST CANCER; CANCER ADJUVANT THERAPY; CTIP GENE; DNA METHYLATION; DNA REPAIR; FEMALE; GENE; GENETIC ANALYSIS; HOMOLOGOUS RECOMBINATION GENE; HUMAN; HUMAN TISSUE; LUMINAL BREAST CANCER; MAJOR CLINICAL STUDY; MDC1 GENE; MRE11 GENE; MULTIPLE CYCLE TREATMENT; NBS1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RAD50 GENE; RAD51 GENE; RNF168 GENE; RNF8 GENE; TREATMENT RESPONSE; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE; UBIQUITIN CONJUGATING ENZYME 13 GENE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL LINE, TUMOR; CPG ISLANDS; CYCLOPHOSPHAMIDE; DNA METHYLATION; DNA REPAIR; FEMALE; FLUOROURACIL; HOMOLOGOUS RECOMBINATION; HUMANS; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; TAXOIDS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84888378185     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12100     Document Type: Article

References (43)

1. Alvarez, S., Diaz-Uriarte, R., Osorio, A., Barroso, A., Melchor, L., Paz, M.F., Honrado, E., Rodríguez, R., Urioste, M., Valle, L., Díez, O., Cigudosa, J.C., Dopazo, J., Esteller, M. & Benitez, J. (2005) A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation. Clin. Cancer Res. 11, 1146-1153.
2. Audeh, M.W., Carmichael, J., Penson, R.T., Friedlander, M., Powell, B., Bell-McGuinn, K.M., Scott, C., Weitzel, J.N., Oaknin, A., Loman, N., Lu, K., Schmutzler, R.K., Matulonis, U., Wickens, M. & Tutt, A. (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: A proof-of-concept trial. Lancet 376, 245-251.
3. Branham, M.T., Marzese, D.M., Laurito, S.R., Gago, F.E., Orozco, J.I., Tello, O.M., Vargas-Roig, L.M. & Roqué, M. (2012) Methylation profile of triple-negative breast carcinomas. Oncogenesis 1, e17.
4. Byrski, T., Huzarski, T., Dent, R., Gronwald, J., Zuziak, D., Cybulski, C., Kladny, J., Gorski, B., Lubinski, J. & Narod, S.A. (2009) Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res. Treat. 115, 359-363.
5. Cantor, S.B., Bell, D.W., Ganesan, S., Kass, E.M., Drapkin, R., Grossman, S., Wahrer, D.C., Sgroi, D.C., Lane, W.S., Haber, D.A. & Livingston, D.M. (2001) BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149-160.
6. Catteau, A., Harris, W.H., Xu, C.F. & Solomon, E. (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18, 1957-1965.
7. Cerne, J.Z., Zong, L., Jelinek, J., Hilsenbeck, S.G., Wang, T., Oesterreich, S. & McGuire, S.E. (2012) BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients. Breast Cancer Res. Treat. 135, 135-143.
8. Chen, Y., Zhou, J., Xu, Y., Li, Z., Wen, X., Yao, L., Xie, Y. & Deng, D. (2009) BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer. Cancer Sci. 100, 1663-1667.
9. Ciccia, A. & Elledge, S.J. (2010) The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179-204.
10. Collins, N., Wooster, R. & Stratton, M.R. (1997) Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br. J. Cancer 76, 1150-1156.
11. Cucer, N., Taheri, S., Ok, E. & Ozkul, Y. (2008) Methylation status of CpG islands at sites -59 to +96 in exon 1 of the BRCA2 gene varies in mammary tissue among women with sporadic breast cancer. J. Genet. 87, 155-158.
12. Dobrovic, A. & Simpfendorfer, D. (1997) Advances in Brief Methylation of the BRCAJ Gene in Sporadic Breast Cancer. Cancer Res. 57, 3347-3350.
13. Esteller, M., Fraga, M.F., Guo, M. et al. (2001) DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001-3007.
14. Esteller, M., Silva, J.M., Dominguez, G., Bonilla, F., Matias-Guiu, X., Lerma, E., Bussaglia, E., Prat, J., Harkes, I.C., Repasky, E.A., Gabrielson, E., Schutte, M., Baylin, S.B. & Herman, J.G. (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92, 564-569.
15. Heikkinen, K., Rapakko, K., Karppinen, S.M., Erkko, H., Knuutila, S., Lundán, T., Mannermaa, A., Børresen-Dale, A.L., Borg, A., Barkardottir, R.B., Petrini, J. & Winqvist, R. (2006) RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27, 1593-1599.
16. Hsu, N.C., Huang, Y.F., Yokoyama, K.K., Chu, P.Y., Chen, F.M. & Hou, M.F. (2013) Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer. PLoS ONE 8, e56256.
17. Jönsson, G., Staaf, J., Vallon-Christersson, J. et al. (2010) Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res. 12, R42.
18. Litman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P.R. & Cantor, S.B. (2005) BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8, 255-265.
19. Livingston, D.M. & Silver, D.P. (2008) Cancer: crossing over to drug resistance. Nature 451, 1066-1067.
20. Magdinier, F., Ribieras, S., Lenoir, G.M., Frappart, L. & Dante, R. (1998) Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene 17, 3169-3176.
21. Margeli, M., Cirauqui, B., Castella, E., Tapia, G., Costa, C., Gimenez-Capitan, A., Barnadas, A., Sanchez Ronco, M., Benlloch, S., Taron, M. & Rosell, R. (2010) The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast Cancer. PLoS ONE 5, e9499.
22. Matros, E., Wang, Z.C., Lodeiro, G., Miron, A., Iglehart, J.D. & Richardson, A.L. (2005) BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res. Treat. 91, 179-186.
23. Meindl, A., Hellebrand, H., Wiek, C. et al. (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet. 42, 410-414.
24. Moelans, C.B., Verschuur-Maes, A.H.J. & Van Diest, P.J. (2011) Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. J. Pathol. 225, 222-231.
25. Moskwa, P., Buffa, F.M., Pan, Y., Panchakshari, R., Gottipati, P., Muschel, R.J., Beech, J., Kulshrestha, R., Abdelmohsen, K., Weinstock, D.M., Gorospe, M., Harris, A.L., Helleday, T. & Chowdhury, D. (2011) miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol. Cell 41, 210-220.
26. Niwa, Y., Oyama, T. & Nakajima, T. (2000) BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers. Jpn. J. Cancer Res. 91, 519-526.
27. Ohta, T., Sato, K. & Wu, W. (2011) The BRCA1 ubiquitin ligase and homologous recombination repair. FEBS Lett. 585, 2836-2844.
28. Potapova, A., Hoffman, A.M., Godwin, A.K., Al-Saleem, T. & Cairns, P. (2008) Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Cancer Res. 68, 998-1002.
29. Rahman, N., Seal, S., Thompson, D. et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39, 165-167.
30. Renwick, A., Thompson, D., Seal, S. et al. (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet. 38, 873-875.
31. Rice, J.C., Ozcelik, H., Maxeiner, P., Andrulis, I. & Futscher, B.W. (2000) Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21, 1761-1765.
32. Sorlie, T., Tibshirani, R., Parker, J. et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA 100, 8418-8423.
33. Steffen, J., Varon, R., Mosor, M. et al. (2004) Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. International journal of cancer. Int. J. Cancer 111, 67-71.
34. Treilleux, I., Chapot, B., Goddard, S., Pisani, P., Angèle, S. & Hall, J. (2007) The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase. Histopathol 51, 63-69.
35. Turner, N.C., Reis-Filho, J.S., Russell, A.M., Springall, R.J., Ryder, K., Steele, D., Savage, K., Gillett, C.E., Schmitt, F.C., Ashworth, A. & Tutt, A.N. (2007) BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26, 2126-2132.
36. Tutt, A., Robson, M., Garber, J.E., Domchek, S.M., Audeh, M.W., Weitzel, J.N., Friedlander, M., Arun, B., Loman, N., Schmutzler, R.K., Wardley, A., Mitchell, G., Earl, H., Wickens, M. & Carmichael, J. (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 376, 235-244.
37. Vo, Q.N., Kim, W.J., Cvitanovic, L., Boudreau, D.A., Ginzinger, D.G. & Brown, K.D. (2004) The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene 23, 9432-9437.
38. Watanabe, Y., Kim, H.S., Castoro, R.J., Chung, W., Estecio, M.R., Kondo, K., Guo, Y., Ahmed, S.S., Toyota, M., Itoh, F., Suk, K.T., Cho, M.Y., Shen, L., Jelinek, J. & Issa, J.P. (2009) Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology 136, 2149-2158.
39. Wei, M., Grushko, T.A., Dignam, J., Hagos, F., Nanda, R., Sveen, L., Xu, J., Fackenthal, J., Tretiakova, M., Das, S. & Olopade, O.I. (2005) BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res. 65, 10692-10699.
40. Wei, M., Xu, J., Dignam, J., Nanda, R., Sveen, L., Fackenthal, J., Grushko, T.A. & Olopade, O.I. (2008) Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers. Breast Cancer Res. Treat. 111, 113-120.
41. Xu, X., Gammon, M.D., Zhang, Y., Bestor, T.H., Zeisel, S.H., Wetmur, J.G., Wallenstein, S., Bradshaw, P.T., Garbowski, G., Teitelbaum, S.L., Neugut, A.I., Santella, R.M. & Chen, J. (2009) BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res. Treat. 115, 397-404.
42. Xu, Y., Diao, L., Chen, Y., Liu, Y., Wang, C., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., Deng, D., Narod, S.A. & Xie, Y. (2013) Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy. Annals Oncol. 24, 1498-1505.
43. Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B. & Yu, X. (2009) PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr. Biol. 19, 524-529.